Atenolol treatment for severe infantile hemangiomas: comparison with a propranolol group of our centre

Abstract

Infantile hemangiomas (IHs) are common benign vascular tumors of infancy¹. Although most of them tend to resolve spontaneously, it is estimated that approximately 10% require intervention due to complications or disfigurements^2‐4. The discovery of the inhibitory effects of propranolol, a non selective b blocker, during the prolipherative phase of IHs was an important development in the treatment of IHs, though its mechanism of action is not yet clear⁴.

This article is protected by copyright. All rights reserved.

http://bit.ly/2t1UFxi